Off-label Drug Coverage
Off-Label Drug Coverage is a health insurance policy provision that determines reimbursement for pharmaceuticals prescribed in accordance with medically accepted indications not formally approved by regulatory authorities.
55
Publications
1.9K
Citations
214
Authors
123
Institutions
Publications per year
2017–2026
11
Parents
55
1–5 of 55
214
3
h-index
3
h-index
3
h-index
2
h-index
2
h-index
1–5 of 214
123
University of Chicago
Chicago, United States
5 h-index
13 publications
402 citations
Harvard University
Cambridge, United States
4 h-index
6 publications
303 citations

Brigham and Women's Hospital
Boston, United States
3 h-index
6 publications
334 citations
Harvard Pilgrim Health Care
Boston, United States
2 h-index
2 publications
73 citations
University of Illinois Chicago
Chicago, United States
2 h-index
3 publications
204 citations
University of California, San Francisco
San Francisco, United States
2 h-index
8 publications
239 citations
University of Chicago Medical Center
Chicago, United States
2 h-index
3 publications
159 citations
Ludwig-Maximilians-Universität München
Munich, Germany
2 h-index
5 publications
81 citations
1–8 of 123
3 publications · 93 citations
3
h-index
Repository · 3 publications · 88 citations
3
h-index
2 publications · 92 citations
2
h-index
2 publications · 39 citations
2
h-index
2 publications · 47 citations
2
h-index
1–5